Cantor Fitzgerald analyst Ross Osborn raised the price target on AxoGen, Inc. (NASDAQ: AXGN) to $24.00 (from $22.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

AxoGen, Inc. (AXGN) PT Raised to $26 at Canaccord GenuityFebruary 25, 2025 4:39 PM AxoGen, Inc. (AXGN) PT Raised to $25 at Raymond JamesFebruary 25, 2025 4:00 PM AxoGen, Inc. (AXGN) PT Raised to $25 at Leerink PartnersFebruary 25, 2025 1:07 PM